Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistMolluscumaway LLC was cited for selling three unapproved new drugs—MolluscumAway Hydrating Patches, Little Skins Smoothing Skin Ointment, and Little Skins Gentle Body Wash—through their website and social media platforms in violation of sections 301(d) and 505(a) of the Federal Food, Drug, and Cosmetic Act. The products were marketed to treat molluscum contagiosum, a viral skin infection for which no legally marketed over-the-counter drugs exist, and the FDA determined that this condition is not amenable to self-diagnosis and treatment without professional medical evaluation. The company's products lacked FDA approval before introduction into interstate commerce, and their marketing directed consumers to purchase these unapproved drugs online without the medical oversight necessary to rule out more serious conditions such as skin cancer or fungal infections.